Host-reactive CD8+ memory stem cells in graft-versus-host disease
- PMID: 16288282
- DOI: 10.1038/nm1326
Host-reactive CD8+ memory stem cells in graft-versus-host disease
Abstract
Graft-versus-host disease (GVHD) is caused by alloreactive donor T cells that trigger host tissue injury. GVHD develops over weeks or months, but how this immune response is maintained over time is unknown. In mouse models of human GVHD, we identify a new subset of postmitotic CD44(lo)CD62L(hi)CD8(+) T cells that generate and sustain all allogeneic T-cell subsets in GVHD reactions, including central memory, effector memory and effector CD8(+) T cells, while self-renewing. These cells express Sca-1, CD122 and Bcl-2, and induce GVHD upon transfer into secondary recipients. The postmitotic CD44(lo)CD62L(hi)CD8(+) T cells persist throughout the course of GVHD, are generated in the initial phase in response to alloantigens and dendritic cells and require interleukin-15. Thus, their long life, ability to self-renew and multipotentiality define these cells as candidate memory stem cells. Memory stem cells will be important targets for understanding and influencing diverse chronic immune reactions, including GVHD.
Comment in
-
Memory stem cells sustain disease.Nat Med. 2005 Dec;11(12):1282-3. doi: 10.1038/nm1205-1282. Nat Med. 2005. PMID: 16333266 No abstract available.
Similar articles
-
Memory stem cells sustain disease.Nat Med. 2005 Dec;11(12):1282-3. doi: 10.1038/nm1205-1282. Nat Med. 2005. PMID: 16333266 No abstract available.
-
Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.Transplantation. 2009 Jul 27;88(2):188-97. doi: 10.1097/TP.0b013e3181ac14ce. Transplantation. 2009. PMID: 19623013
-
Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 2):22-30. doi: 10.1016/j.bbmt.2005.11.004. Biol Blood Marrow Transplant. 2006. PMID: 16399598 Clinical Trial.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Are CD8+CD122+ cells regulatory T cells or memory T cells?Hum Immunol. 2008 Nov;69(11):751-4. doi: 10.1016/j.humimm.2008.08.285. Epub 2008 Sep 24. Hum Immunol. 2008. PMID: 18817826 Review.
Cited by
-
Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses.Viruses. 2016 May 23;8(5):139. doi: 10.3390/v8050139. Viruses. 2016. PMID: 27223301 Free PMC article.
-
Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.Blood. 2016 Jun 23;127(25):3270-80. doi: 10.1182/blood-2015-05-644476. Epub 2016 May 3. Blood. 2016. PMID: 27143255 Free PMC article.
-
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines.Elife. 2022 Mar 22;11:e71156. doi: 10.7554/eLife.71156. Elife. 2022. PMID: 35314027 Free PMC article.
-
High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors.J Exp Med. 2018 Oct 1;215(10):2520-2535. doi: 10.1084/jem.20180684. Epub 2018 Aug 28. J Exp Med. 2018. PMID: 30154266 Free PMC article.
-
Understanding Subset Diversity in T Cell Memory.Immunity. 2018 Feb 20;48(2):214-226. doi: 10.1016/j.immuni.2018.02.010. Immunity. 2018. PMID: 29466754 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
